Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation

Surgery

Volumn 126, Issue 2, 1999, Pages 299-304

  Thomas, Francis T ^a,b   Contreras, Juan L ^a   Bilbao, Guadalupe ^a   Ricordi, Camillo ^a   Curiel, David ^a   Thomas, Judith M ^a  

^a Gene Therapy Center   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROTECTION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE TRANSFER; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RHESUS MONKEY;

EID: 0032853443     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70169-8     Document Type: Article

References (21)

1. 1. Ricordi C. The structure of scientific revolutions: a cell transplant. Cell Transplant 1995;4:357-60.
2. 2. Hering BJ, Ricordi C. Islet transplantation for patients with type I diabetes. Graft 1999;2(1):12-27.
3. 3. Thomas F, Contreras J, Oliver P. The importance of tensegrity in islet long-term culture viability. Transplantation 1998;65;S122.
4. 4. Thomas F, Contreras J, Bilbao L, Invarardi L, Thomas J. An improved technique for isolating pig islets: the importance of tensegrity in islet long-term culture viability. Transplant Proc 1999;31;633-4.
5. 5. Ingber D. The architecture of life. Sci Am 1998;Jan:48-57.
6. 6. Frisch SM, Rouslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997;9:701-6.
7. 7. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619-26.
8. 8. Frisch SM, Vuori K, Kelaita D, Sicks S. Role for Jun-N-terminal linase in anoikis: suppression by bcl-2 and crmA. J Cell Biol 1996;135:1377-82.
9. 9. Davalli AM, Scaglia L, Zanger DH, Hollister J. Bonner-Weir S, Weir GC. Vulnerability of islets in the immediate post-transplant period. Diabetes 1996;45:1111-7.
10. 10 Hering BJ, Bretzel RG, Federlin K. Current status of clinical islet transplantation. Hormone Metabol Res 1988;20:537-45.
11. 11. Ricordi C, Alejandro R, Rilo HH, Carroll PB, Tzakis AG, Starzl T, Mintz DH. Long-term in vivo function of human mantled islets obtained by incomplete pancreatic dissociation and purifiration. Transplant Proc 1995;27:3382.
12. 12. Kaufman DB, Gores PF, Field MJ, Farney AC, Gruber SA, Stephanian E, et al. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 1994,43:778-83.
13. 13. Contreras J, Bilbao G, Oliver P, Mikheeva G, Gomez-Navarro J, Eckhoff D, et al. Cytoprotection of pancreatic islets in culture by genetic modification with the anti-apoptotic Bcl-2. Gene Transplant 1998;65:S155.
14. 14. Bilbao G, Contreras J, Gomez-Navarro J, Eckhoff D, Mikheeva G, Krasnykh V, et al. Genetic modification of liver grafts with an adenovirus encoding Bcl-2 for improved organ preservation. Transplantation. In press.
15. 15. Bilbao G, Contreras J, Mikheeva G, Krasnykh V, Eckhoff D, Thomas F, et al. Genetic cytoprotection of human endothelial cells during the preservation time with an adenoviral vector encoding the anti-apoptotic human Bcl-2 gene. Transplant Proc 1999;31:1012-5.
16. 16. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, editor. Methods In molecular biology: gene transfer and expression protocols. 7th ed. Clfton, NJ: Press; 1991. p. 109-28.
17. 17. Weber M, Deng S, Kucher T, Shaked A, Retchum RJ, Brayman KL. Adenoviral transduction of isolated pancreatic islets: a study of programmed cell death (apoptosis) and islet function. J Surg Res 1997;69:23-32.
18. 18. Csernus V, Hammer T, Peschke D. Dynamic insulin secretion from perifused rat pancreatic islets. Cell Mol Life Sci 1998;54:733-43.
19. 19. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
20. 20. Thomas F, Contreras J, Cartner S, Eckhoff D, Huang Z, Neville D, Thomas J. Reversal of naturally occurring insulinopenic diabetes and induction of isolated islet xenograft tolerance in a pre-clinical study. Transplant Proc. In Press.
21. 21. Thomas F, Contreras J, Cartner S, Eckhoff D, Huang Z, Neville D, et al. Reversal of naturally occurring diabetes in primates by unmodified islet xenograffs without chronic immunosuppression. Transplantation. In press.